{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:16:23Z","timestamp":1778948183855,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01624-1","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:54:23Z","timestamp":1744718063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ultrasound-based radiomics for predicting the five major histological subtypes of epithelial ovarian cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"3","key":"1624_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA cancer J Clin"},{"issue":"2","key":"1624_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA cancer J Clin"},{"issue":"1","key":"1624_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/AOG.0000000000000917","volume":"126","author":"J Prat","year":"2015","unstructured":"Prat J. Staging classification for Cancer of the ovary, fallopian tube, and peritoneum: abridged republication of guidelines from the international federation of gynecology and obstetrics (FIGO). FIGO Comm Gynecologic Oncol. 2015;126(1):171\u20134. https:\/\/doi.org\/10.1097\/AOG.0000000000000917.","journal-title":"FIGO Comm Gynecologic Oncol"},{"issue":"2","key":"1624_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/gyno.1995.1027","volume":"56","author":"AP Makar","year":"1995","unstructured":"Makar AP, Baekelandt M, Trop\u00e9 CG, Kristensen GB. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol. 1995;56(2):175\u201380. https:\/\/doi.org\/10.1006\/gyno.1995.1027.","journal-title":"Gynecol Oncol"},{"issue":"10177","key":"1624_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240\u201353. https:\/\/doi.org\/10.1016\/S0140-6736(18)32552-2.","journal-title":"Lancet"},{"issue":"4","key":"1624_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.23736\/S0026-4806.19.06078-6","volume":"110","author":"B Chiofalo","year":"2019","unstructured":"Chiofalo B, Bruni S, Certelli C, Sperduti I, Baiocco E, Vizza E. Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis. Minerva Med. 2019;110(4):330\u201340. https:\/\/doi.org\/10.23736\/S0026-4806.19.06078-6.","journal-title":"Minerva Med"},{"key":"1624_CR7","doi-asserted-by":"publisher","unstructured":"Landen CN Jr., Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol. 2008;26(6):995\u20131005. https:\/\/doi.org\/10.1200\/JCO.2006.07.9970.","DOI":"10.1200\/JCO.2006.07.9970"},{"issue":"2","key":"1624_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PGP.0b013e318161e4f5","volume":"27","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151\u201360. https:\/\/doi.org\/10.1097\/PGP.0b013e318161e4f5.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"1624_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1148\/radiol.211868","volume":"304","author":"K Hack","year":"2022","unstructured":"Hack K, Gandhi N, Bouchard-Fortier G, Chawla TP, Ferguson SE, Li S, et al. External validation of O-RADS US risk stratification and management system. Radiology. 2022;304(1):114\u201320. https:\/\/doi.org\/10.1148\/radiol.211868.","journal-title":"Radiology"},{"issue":"5","key":"1624_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/uog.20163","volume":"53","author":"JJ Hidalgo","year":"2019","unstructured":"Hidalgo JJ, Ros F, Aub\u00e1 M, Errasti T, Olartecoechea B, Ruiz-Zambrana \u00c1, et al. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk. Ultrasound Obstet Gynecol. 2019;53(5):693\u2013700. https:\/\/doi.org\/10.1002\/uog.20163.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"1624_CR11","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-18-3378","volume":"25","author":"E Kawakami","year":"2019","unstructured":"Kawakami E, Tabata J, Yanaihara N, Ishikawa T, Koseki K, Iida Y, et al. Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian Cancer based on blood biomarkers. Clin Cancer Res. 2019;25(10):3006\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3378.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1624_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13073-021-00952-5","volume":"13","author":"BM Barnes","year":"2021","unstructured":"Barnes BM, Nelson L, Tighe A, Burghel GJ, Lin IH, Desai S, et al. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes. Genome Med. 2021;13(1):140. https:\/\/doi.org\/10.1186\/s13073-021-00952-5.","journal-title":"Genome Med"},{"issue":"1","key":"1624_CR13","doi-asserted-by":"publisher","first-page":"e1700181","DOI":"10.1002\/prca.201700181","volume":"13","author":"O Klein","year":"2019","unstructured":"Klein O, Kanter F, Kulbe H, Jank P, Denkert C, Nebrich G, et al. MALDI-Imaging for classification of epithelial ovarian Cancer histotypes from a tissue microarray using machine learning methods. Proteom Clin Appl. 2019;13(1):e1700181. https:\/\/doi.org\/10.1002\/prca.201700181.","journal-title":"Proteom Clin Appl"},{"issue":"10","key":"1624_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.diii.2018.11.007","volume":"100","author":"S Nougaret","year":"2019","unstructured":"Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, et al. Ovarian cancer: an update on imaging in the era of radiomics. Diagn Interv Imaging. 2019;100(10):647\u201355. https:\/\/doi.org\/10.1016\/j.diii.2018.11.007.","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"1624_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377. https:\/\/doi.org\/10.1148\/radiol.2015151169.","journal-title":"Radiology"},{"issue":"6","key":"1624_CR16","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00261-018-1649-2","volume":"44","author":"AT Scrima","year":"2019","unstructured":"Scrima AT, Lubner MG, Abel EJ, Havighurst TC, Shapiro DD, Huang W, et al. Texture analysis of small renal cell carcinomas at MDCT for predicting relevant histologic and protein biomarkers. Abdom Radiol. 2019;44(6):1999\u20132008. https:\/\/doi.org\/10.1007\/s00261-018-1649-2.","journal-title":"Abdom Radiol"},{"issue":"3","key":"1624_CR17","doi-asserted-by":"publisher","first-page":"e0118261","DOI":"10.1371\/journal.pone.0118261","volume":"10","author":"O Grove","year":"2015","unstructured":"Grove O, Berglund AE, Schabath MB, Aerts HJ, Dekker A, Wang H, et al. Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. PLoS ONE. 2015;10(3):e0118261. https:\/\/doi.org\/10.1371\/journal.pone.0118261.","journal-title":"PLoS ONE"},{"issue":"1","key":"1624_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12880-022-00879-2","volume":"22","author":"ZP Tang","year":"2022","unstructured":"Tang ZP, Ma Z, He Y, Liu RC, Jin BB, Wen DY, et al. Ultrasound-based radiomics for predicting different pathological subtypes of epithelial ovarian cancer before surgery. BMC Med Imaging. 2022;22(1):147. https:\/\/doi.org\/10.1186\/s12880-022-00879-2.","journal-title":"BMC Med Imaging"},{"issue":"1136","key":"1624_CR19","doi-asserted-by":"publisher","first-page":"20211332","DOI":"10.1259\/bjr.20211332","volume":"95","author":"F Yao","year":"2022","unstructured":"Yao F, Ding J, Lin F, Xu X, Jiang Q, Zhang L, et al. Nomogram based on ultrasound radiomics score and clinical variables for predicting histologic subtypes of epithelial ovarian cancer. Br J Radiol. 2022;95(1136):20211332. https:\/\/doi.org\/10.1259\/bjr.20211332.","journal-title":"Br J Radiol"},{"key":"1624_CR20","volume-title":"WHO classification of tumours","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. WHO classification of tumours. 4th ed. Lyon: WHO; 2014.","edition":"4"},{"issue":"2","key":"1624_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(2):191\u2013226. https:\/\/doi.org\/10.6004\/jnccn.2021.0007.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"1624_CR22","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65(6):2162\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3924.","journal-title":"Cancer Res"},{"issue":"2","key":"1624_CR23","doi-asserted-by":"publisher","first-page":"188634","DOI":"10.1016\/j.bbcan.2021.188634","volume":"1876","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhang P, Zhang K, Huang C. The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188634. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188634.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"1624_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13048-024-01487-0","volume":"17","author":"A Margoni","year":"2024","unstructured":"Margoni A, Gargalionis AN, Papavassiliou AG. CA-125: CA72-4 ratio-towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatment. J Ovarian Res. 2024;17(1):164. https:\/\/doi.org\/10.1186\/s13048-024-01487-0.","journal-title":"J Ovarian Res"},{"issue":"3","key":"1624_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ygyno.2020.09.025","volume":"159","author":"C Landolfo","year":"2020","unstructured":"Landolfo C, Achten ETL, Ceusters J, Baert T, Froyman W, Heremans R, et al. Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors. Gynecol Oncol. 2020;159(3):811\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.025.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1624_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/uog.22002","volume":"56","author":"P Anfelter","year":"2020","unstructured":"Anfelter P, Testa A, Chiappa V, Froyman W, Fruscio R, Guerriero S, et al. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors). Ultrasound Obstet Gynecol. 2020;56(2):276\u201384. https:\/\/doi.org\/10.1002\/uog.22002.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"1624_CR27","doi-asserted-by":"publisher","first-page":"e2245141","DOI":"10.1001\/jamanetworkopen.2022.45141","volume":"5","author":"M Wang","year":"2022","unstructured":"Wang M, Perucho JAU, Hu Y, Choi MH, Han L, Wong EMF, et al. Computed tomographic radiomics in differentiating histologic subtypes of epithelial ovarian carcinoma. JAMA Netw Open. 2022;5(12):e2245141. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.45141.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1624_CR28","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1007\/s00330-019-06124-9","volume":"29","author":"H Zhang","year":"2019","unstructured":"Zhang H, Mao Y, Chen X, Wu G, Liu X, Zhang P, et al. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study. Eur Radiol. 2019;29(7):3358\u201371. https:\/\/doi.org\/10.1007\/s00330-019-06124-9.","journal-title":"Eur Radiol"},{"issue":"1","key":"1624_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00330-020-07091-2","volume":"31","author":"J Jian","year":"2021","unstructured":"Jian J, Li Y, Pickhardt PJ, Xia W, He Z, Zhang R, et al. MR image-based radiomics to differentiate type \u0399 and type \u0399\u0399 epithelial ovarian cancers. Eur Radiol. 2021;31(1):403\u201310. https:\/\/doi.org\/10.1007\/s00330-020-07091-2.","journal-title":"Eur Radiol"},{"issue":"1","key":"1624_CR30","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/s41598-022-20653-2","volume":"12","author":"Y Jung","year":"2022","unstructured":"Jung Y, Kim T, Han MR, Kim S, Kim G, Lee S, et al. Ovarian tumor diagnosis using deep convolutional neural networks and a denoising convolutional autoencoder. Sci Rep. 2022;12(1):17024. https:\/\/doi.org\/10.1038\/s41598-022-20653-2.","journal-title":"Sci Rep"},{"key":"1624_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.media.2017.04.008","volume":"39","author":"A BenTaieb","year":"2017","unstructured":"BenTaieb A, Li-Chang H, Huntsman D, Hamarneh G. A structured latent model for ovarian carcinoma subtyping from histopathology slides. Med Image Anal. 2017;39:194\u2013205. https:\/\/doi.org\/10.1016\/j.media.2017.04.008.","journal-title":"Med Image Anal"},{"key":"1624_CR32","doi-asserted-by":"publisher","unstructured":"Wu M, Yan C, Liu H, Liu Q. Automatic classification of ovarian cancer types from cytological images using deep convolutional neural networks. Biosci Rep. 2018;38(3). https:\/\/doi.org\/10.1042\/BSR20180289.","DOI":"10.1042\/BSR20180289"},{"issue":"12","key":"1624_CR33","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/s41379-022-01146-z","volume":"35","author":"H Farahani","year":"2022","unstructured":"Farahani H, Boschman J, Farnell D, Darbandsari A, Zhang A, Ahmadvand P, et al. Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images. Mod Pathol. 2022;35(12):1983\u201390. https:\/\/doi.org\/10.1038\/s41379-022-01146-z.","journal-title":"Mod Pathol"},{"key":"1624_CR34","doi-asserted-by":"publisher","first-page":"104070","DOI":"10.1016\/j.jbi.2022.104070","volume":"129","author":"X Ding","year":"2022","unstructured":"Ding X, Yang F, Ma F. An efficient model selection for linear discriminant function-based recursive feature elimination. J Biomed Inf. 2022;129:104070. https:\/\/doi.org\/10.1016\/j.jbi.2022.104070.","journal-title":"J Biomed Inf"},{"issue":"7","key":"1624_CR35","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1109\/TNNLS.2020.3009776","volume":"32","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Jung C. GBDT-MO: Gradient-Boosted decision trees for multiple outputs. IEEE Trans Neural Netw Learn Syst. 2021;32(7):3156\u201367. https:\/\/doi.org\/10.1109\/TNNLS.2020.3009776.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"1624_CR36","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"1624_CR37","unstructured":"Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al. SEER cancer statistics review, 1975\u20132001. Bethesda (MD): National Cancer Institute."},{"key":"1624_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijsu.2018.02.006","volume":"52","author":"J Zhou","year":"2018","unstructured":"Zhou J, Zhang WW, Zhang QH, He ZY, Sun JY, Chen QH, et al. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study. Int J Surg. 2018;52:11\u20135. https:\/\/doi.org\/10.1016\/j.ijsu.2018.02.006.","journal-title":"Int J Surg"},{"issue":"6","key":"1624_CR39","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1525-1438.2007.00931.x","volume":"17","author":"P Harter","year":"2007","unstructured":"Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler-Eckhoff A, Traut A, et al. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer. 2007;17(6):1238\u201344. https:\/\/doi.org\/10.1111\/j.1525-1438.2007.00931.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1624_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/gyno.2001.6232","volume":"82","author":"SM Eisenkop","year":"2001","unstructured":"Eisenkop SM, Spirtos NM. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol Oncol. 2001;82(1):143\u20139. https:\/\/doi.org\/10.1006\/gyno.2001.6232.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1624_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ejso.2013.11.026","volume":"40","author":"A Ferrero","year":"2014","unstructured":"Ferrero A, Ditto A, Giorda G, Gadducci A, Greggi S, Daniele A, et al. Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study. Eur J Surg Oncol. 2014;40(7):891\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2013.11.026.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"1624_CR42","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97(8):560\u20136. https:\/\/doi.org\/10.1093\/jnci\/dji102.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"1624_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380(9):822\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1808424.","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"1624_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/annonc\/mdt333","volume":"24","author":"JA Ledermann","year":"2013","unstructured":"Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):24\u201332. https:\/\/doi.org\/10.1093\/annonc\/mdt333.","journal-title":"Ann Oncol"},{"issue":"1","key":"1624_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ygyno.2021.10.072","volume":"164","author":"VM Witjes","year":"2022","unstructured":"Witjes VM, van Bommel MHD, Ligtenberg MJL, Vos JR, Mourits MJE, Ausems M, et al. Probability of detecting germline BRCA1\/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis. Gynecol Oncol. 2022;164(1):221\u201330. https:\/\/doi.org\/10.1016\/j.ygyno.2021.10.072.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"1624_CR46","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","volume":"105","author":"J Moretta","year":"2018","unstructured":"Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, et al. [The French genetic and Cancer consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]. Bull Cancer. 2018;105(10):907\u201317. https:\/\/doi.org\/10.1016\/j.bulcan.2018.08.003.","journal-title":"Bull Cancer"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01624-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:54:25Z","timestamp":1744718065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01624-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01624-1","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"13 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for patients\u2019 informed consent was waived owing to the retrospective study design. It was approved by the ethics committee of Shengjing hospital and the committee\u2019s reference number was 2023PS1208K.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}